Neoplastic stem cells in cutaneous lymphomas: Evidence and clinical implications

Archives of Dermatology

Volumn 140, Issue 9, 2004, Pages 1156-1160

  Gniadecki, Robert ^a  

^a BISPEBJERG HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; CARCINOGENESIS; CELL TRANSFORMATION; CLINICAL FEATURE; HUMAN; HUMAN CELL; LYMPHOID CELL; LYMPHOID PRECURSOR CELL; LYMPHOMA CELL; LYMPHOMA STEM CELL; NEOPLASTIC STEM CELL; NONHUMAN; NOTE; PRIORITY JOURNAL; SKIN LYMPHOMA; STEM CELL; TUMOR CELL;

CELL TRANSFORMATION, NEOPLASTIC; EVIDENCE-BASED MEDICINE; FEMALE; HUMANS; INCIDENCE; LYMPHOMA, T-CELL, CUTANEOUS; MALE; MOLECULAR BIOLOGY; PRECANCEROUS CONDITIONS; PROGNOSIS; RISK ASSESSMENT; TUMOR STEM CELLS;

EID: 4544252694     PISSN: 0003987X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archderm.140.9.1156     Document Type: Note

References (36)

1. Zutter MM, Korsmeyer SJ. The biology of low-grade malignant lymphoma. In: Canellos GP, Lister TA, Sklar JL, eds. The Lymphomas. Philadelphia, Pa: WB Saunders; 1998:337-351.
2. Wood GS. Analysis of clonality in cutaneous T cell lymphoma and associated diseases. Ann N Y Acad Sci. 2001;941:26-30.
3. Veelken H, Wood GS, Sklar J. Molecular staging of cutaneous T-cell lymphoma: evidence for systemic involvement in early disease. J Invest Dermatol 1995;104:889-894.
4. Smalley M, Ashworth A. Stem cells and breast cancer: a field in transit. Nat Rev Cancer. 2003; 3:832-844.
5. Passegué E, Jamieson CHM, Ailles LE, et al. Normal and leukemic hematopoiesis: are leukemias a stem cell disorder or a reacquisition of stem cell characteristics? Proc Natl Acad Sci U S A. 2003; 100(suppl 1):11842-11849.
6. Reya T, Morrisson SJ, Clarke MF, et al. Stem cells, cancer, and cancer stem cells. Nature. 2001;414: 105-111.
7. Morrison SJ, Uchida N, Weissman IL. The biology of hematopoietic stem cells. Annu Rev Cell Dev Biol. 1995;11:35-71.
8. Park CH, Bergsagel DE, McCulloch EA. Mouse myeloma tumor stem cells: a primary cell culture assay. J Natl Cancer Inst. 1971;46:411-422.
9. Bonnet D, Dick JE. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med. 1997;3: 730-737.
10. Gunsilius E, Duba HC, Petzer AL, et al. Evidence from a leukaemia model for maintenance of vascular endothelium by bone-marrow-derived endothelial cells. Lancet. 2000;355:1688-1691.
11. Cleary ML, Galili N, Trela M, et al. Single cell origin of bigenotypic and biphenotypic B cell proliferations in human follicular lymphomas. J Exp Med. 1988;167:582-597.
12. Sanchez M-L, Almeida J, Gonzalez D, et al. Incidence and clinicobiologic characteristics of leukemic B-cell chronic lymphoproliferative disorders with more than one B-cell clone. Blood. 2003; 102:2994-3002.
13. Fend F, Quintanilla-Martinez L, Kumar S, et al, Composite low grade B-cell lymphomas with two immunophenotypically distinct cell populations are true biclonal lymphomas: a molecular analysis using laser capture microdissection. Am J Pathol. 1999;154:1857-1866.
14. van den Berg A, Maggio E, Rust R, et al. Clonal relation in a case of CLL, ALCL, and Hodgkin composite lymphoma. Blood. 2002;100:1425-1429.
15. Weiss LM, Wood GS, Trela M, et al. Clonal T-cell populations in lymphomatoid papulosis: evidence of a lymphoproliferative origin for a clinically benign disease. N Engl J Med. 1986;315: 475-479.
16. Davis TH, Morton CC, Miller-Cassman R, et al. Hodgkin's disease, lymphomatoid papulosis and cutaneous T-cell lymphoma derived from a common T-cell clone. N Engl J Med. 1992;326:1115-1122.
17. + lymphoproliferative disorders: a report from the Dutch Cutaneous Lymphoma Group on the long-term follow-up data of 219 patients and guidelines for diagnosis and treatment. Blood. 2000;95:3653-3661.
18. Chott A, Vonderheid EC, Olbricht S, et al. The same dominant T cell clone is present in multiple regressing skin lesions and associated T cell lymphomas of patients with lymphomatoid papulosis. J Invest Dermatol. 1996;106:696-700.
19. Assaf C, Hummel M, Dippel E, et al. Common clonal T-cell origin in a patient with T-prolymphocytic leukemia and associated cutaneous T-cell lymphomas. Br J Haematol. 2003;120:488-491.
20. Gniadecki R, Lukowsky A, Rossen K, et al. Bone marrow precursor of extranodal T-cell lymphoma. Blood. 2003;102:3797-3799.
21. Rivet J, Moreau D, Daneshpouy M, et al. T-cell lymphoma with eosinophilia of donor origin occurring 12 years after allogeneic bone marrow transplantation for myeloma [case report]. Transplantation. 2001;72:965.
22. Schouten HC, Hopman AH, Haesevoets AM, et al. Large-cell anaplastic non-Hodgkin's lymphoma originating in donor cells after allogenic bone marrow transplantation. Br J Haematol. 1995;91:162-166.
23. Berg KD, Brinster NK, Huhn KM, et al. Transmission of a T-cell lymphoma by allogeneic bone marrow transplantation. N Engl J Med. 2001;345: 1458-1463.
24. + cells in lymphomatoid papulosis demonstrates a common clonal T-cell origin. Blood. 2002;100:578-584.
25. Vega F, Luthra R, Medeiros J, et al. Clonal heterogeneity in mycosis fungoides and its relationship to clinical course. Blood. 2002;100:3369-3373.
26. Goudie RB, Soukop M, Dagg JH, Lee FD. Hypothesis: symmetrical cutaneous lymphoma. Lancet. 1990;335:316-318.
27. Muche JM, Lukowsky A, Heim J, et al. Demonstration of frequent occurrence of clonal T cells in the peripheral blood but not in the skin of patients with small plaque parapsoriasis. Blood. 1999;94:1409-1417.
28. Miyamoto T, Nagafuji K, Akashi K, et al. Persistence of multipotent progenitors expressing AML1/ETO transcripts in long-term remission patients with t(8;21) acute myelogenous leukemia. Blood. 1996;87:4789-4796.
29. Holyoake TL, Jiang X, Drummond MW, et al. Elucidating critical mechanisms of deregulated stem cell turnover in the chronic phase of chronic myeloid leukemia. Leukemia. 2002;16:549-558.
30. Kadin ME. Extracutaneous origin of lymphomatoid papulosis [abstract]. Blood. 2003;102: 3468.
31. García-Ojeda ME, Dejbakhsh-Jones S, Weissman IL, Strober S. An alternate pathway for T cell development supported by the bone marrow microenvironment: recapitulation of thymic maturation. J Exp Med. 1998;187:1813-1823.
32. Suzuki K, Oida T, Hamada H, et al. Gut cryptopatches: direct evidence of extrathymic anatomical sites for intestinal T lymphopoiesis. Immunity. 2000;13:691-702.
33. Guy-Grand D, Azogui O, Celli S, et al. Extrathymic T cell lymphopoiesis: ontogeny and contribution to gut intraepithelial lymphocytes in athymic and euthymic mice. J Exp Med. 2003;197:333-341.
34. Clark RA, Kupper TS. Making a thymus from skin: a thymic construct of human keratinocytes and fibroblasts supports T cell development. Poster presented at: Joint Meeting of the Society of Investigative Dermatology, European Society of Dermatological Research and Japanese Society of Investigative Dermatology; 2003; Miami Beach, Fla.
35. Slaughter DP, Southwick HW, Smejkal W. "Field cancerization" in oral stratified squamous epithelium: clinical implications of multicentric origin. Cancer. 1953;6:963-968.
36. Braakhuis BJ. A genetic explanation of Slaughter's concept of field cancerization: evidence and clinical applications. Cancer Res. 2003;63:1727-1730.